Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous Coronary Intervention, 2008-2016-Reference-Cited by-同舟云学术

Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous Coronary Intervention, 2008-2016

Published:2018-07-01 Issue:7 Volume:178 Page:943
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Dayoub Elias J.¹²,Seigerman Matthew¹,Tuteja Sony¹,Kobayashi Taisei³⁴⁵,Kolansky Daniel M.³,Giri Jay³⁴⁵,Groeneveld Peter W.¹²⁴⁵

Affiliation:

1. Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia

2. Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia

3. Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia

4. Center for Cardiovascular Outcomes, Quality, and Evaluative Research, University of Pennsylvania, Philadelphia

5. Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Reference37 articles.

1. Prasugrel versus clopidogrel in patients with acute coronary syndromes.;Wiviott;N Engl J Med,2007

2. Ticagrelor versus clopidogrel in patients with acute coronary syndromes.;Wallentin;N Engl J Med,2009

3. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: an update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery.;Levine;Circulation,2016

4. Contemporary use of ticagrelor in interventional practice (from Blue Cross Blue Shield of Michigan Cardiovascular Consortium).;Karve;Am J Cardiol,2015

5. Contemporary trends in oral antiplatelet agent use in patients treated with percutaneous coronary intervention for acute coronary syndrome.;Kim;J Manag Care Spec Pharm,2017

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Determinants of Response to P2Y12 Inhibitors and Clinical Implications;Interventional Cardiology Clinics;2024-10

2. Comparing Measures of Adherence and Persistence to P2Y12 Inhibitors in Acute Coronary Syndromes;The American Journal of Cardiology;2024-09

3. Genotype-Guided Antiplatelet Therapy;Journal of the American College of Cardiology;2024-09

4. Impact of proton pump inhibitor use on clinical outcomes in East Asian patients receiving clopidogrel following drug-eluting stent implantation;BMC Medicine;2024-08-15

5. Precision Antiplatelet Therapy after Percutaneous Coronary Intervention (Precision PCI) Registry – Informing optimal antiplatelet strategies;Clinical and Translational Science;2024-08